Evidence map›Paper›PMID 41234887›Full record

ArticleTranslational cancer research2025

Unveiling critical genes and molecular subtypes in ovarian cancer: insights into tumor immunity and carbohydrate-lipid metabolism.

Yuxuan Zhang, Wei Zhang, Wenli Xie, Xiangyu Wang, Ping Wei

Abstract read
In one paragraph

Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuxuan ZhangThe First Clinical Medical College, Nanjing Medical University, Nanjing, China.
Wei ZhangObstetrics and Gynecology Department of Binzhou Medical College Affiliated Hospital, Binzhou, China.
Wenli XieDepartment of Gynecology, The Second Hospital of Shandong University, Jinan, China.ORCID https://orcid.org/0009-0003-8030-9015
Xiangyu WangDepartment of Gynecological Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.ORCID https://orcid.org/0000-0002-7469-4127
Ping WeiDepartment of Gynecology, Shandong Public Health Clinical Center, Shandong University, Jinan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ovarian cancer (OC) has the highest mortality rate among all gynecological cancers, yet its pathogenesis remains unclear. This study aims to use integrated bioinformatics methods to identify important biomarkers and subtypes closely related to tumor immunity and fatty acid synthesis in OC. Methods: RNA sequencing data offered with the Gene Expression Omnibus (GEO) were processed. Differentially expressed genes (DEGs) were screened and annotated via Gene Ontology (GO) Enrichment Analysis, Gene Set Variation Analysis (GSVA), and Gene Set Enrichment Analysis (GSEA). Besides, the critical DEGs were used in building the protein-protein interaction (PPI) networks, screening significant subtypes, and constructing risk models. Results: After processing the raw data derived from GEO, we filtered out 1,401 DEGs, which were used in gene enrichment and building the PPI networks. Several processes were enriched. Three subtypes associated with fatty acid synthesis and tumor immunity in OC were identified based on six critical genes ( Conclusions: This study enhances our understanding of the complex molecular mechanisms underlying OC by highlighting the interplay between tumor immunity and fatty acid synthesis. The identification of three distinct subtypes based on key genes provides a new framework for categorizing OC patients, which could lead to more personalized therapeutic approaches. The prognostic model related to fatty acid synthesis not only offers potential biomarkers for predicting patient outcomes but also suggests new avenues for targeted therapies. These findings could pave the way for more effective immune-based treatments and improve the prognosis for OC patients. Future research should focus on validating these biomarkers and exploring their functional roles in OC pathogenesis and treatment response.

Indexed as

bioinformaticscarbohydrate-lipid metabolismmolecular markersOvarian cancer (OC)tumor immune

Identifiers

PMID41234887
PMCPMC12605307

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.